GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (OSTO:ACTI) » Definitions » Shiller PE Ratio

Active Biotech AB (OSTO:ACTI) Shiller PE Ratio : (As of Jun. 10, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Active Biotech AB Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Active Biotech AB Shiller PE Ratio Historical Data

The historical data trend for Active Biotech AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Active Biotech AB Shiller PE Ratio Chart

Active Biotech AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Active Biotech AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Active Biotech AB's Shiller PE Ratio

For the Biotechnology subindustry, Active Biotech AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Active Biotech AB's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Active Biotech AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Active Biotech AB's Shiller PE Ratio falls into.



Active Biotech AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Active Biotech AB's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Active Biotech AB's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.027/132.2054*132.2054
=-0.027

Current CPI (Mar. 2024) = 132.2054.

Active Biotech AB Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.389 100.432 -0.512
201409 -0.384 100.161 -0.507
201412 -0.349 100.225 -0.460
201503 -0.343 99.950 -0.454
201506 -0.428 99.995 -0.566
201509 -0.139 100.228 -0.183
201512 -0.250 100.276 -0.330
201603 -0.102 100.751 -0.134
201606 -0.093 101.019 -0.122
201609 -0.076 101.138 -0.099
201612 -0.082 102.022 -0.106
201703 -0.116 102.022 -0.150
201706 -0.145 102.752 -0.187
201709 -0.051 103.279 -0.065
201712 -0.355 103.793 -0.452
201803 -0.080 103.962 -0.102
201806 -0.051 104.875 -0.064
201809 -0.043 105.679 -0.054
201812 -0.043 105.912 -0.054
201903 -0.043 105.886 -0.054
201906 -0.029 106.742 -0.036
201909 -0.043 107.214 -0.053
201912 -0.091 107.766 -0.112
202003 -0.052 106.563 -0.065
202006 -0.052 107.498 -0.064
202009 -0.043 107.635 -0.053
202012 -0.017 108.296 -0.021
202103 -0.043 108.360 -0.052
202106 -0.052 108.928 -0.063
202109 -0.043 110.338 -0.052
202112 -0.069 112.486 -0.081
202203 -0.063 114.825 -0.073
202206 -0.063 118.384 -0.070
202209 -0.054 122.296 -0.058
202212 -0.079 126.365 -0.083
202303 -0.036 127.042 -0.037
202306 -0.036 129.407 -0.037
202309 -0.036 130.224 -0.037
202312 -0.053 131.912 -0.053
202403 -0.027 132.205 -0.027

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Active Biotech AB  (OSTO:ACTI) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Active Biotech AB Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Active Biotech AB's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Active Biotech AB (OSTO:ACTI) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

Active Biotech AB (OSTO:ACTI) Headlines

No Headlines